Identifying common disease trajectories of Alzheimer’s disease with electronic health records. eBioMedicine, 2025; 118: 105831 DOI: 10.1016/j.ebiom.2025.105831 ...

Instead, UCLA scientists mapped the step-by-step clinical trajectories that precede an Alzheimer’s diagnosis, offering new tools for early detection and prevention. Patterns, not just risk factors ...

The Brief UCLA researchers uncovered four health trajectories that lead to Alzheimer’s disease. The study analyzed nearly 25,000 patients and validated findings in a national cohort. Multi-step ...

Big data from patients and cells points to a new Alzheimer’s therapy Alzheimer’s disease affects 7 million people in the U.S. and causes a relentless decline in cognition, learning, and memory. Yet ...

While Alzheimer’s is a specific disease and the most common cause of dementia, dementia is a broader, "umbrella term that describes a collection of cognitive, functional and behavioral symptoms ...

A new study suggested that not getting enough REM sleep can be an early warning sign of Alzheimer's disease. Here's what a neurologist wants you to know.

For their study, the teams expressed either Tau or Aβ42, a peptide that contributes to plaques in Alzheimer’s disease, selectively in adult fly neurons using a controllable gene expression system. 4 ...

Mayo Clinic researchers validated a new FDA-approved blood test for Alzheimer’s disease, offering a less invasive and more affordable alternative to PET scans and spinal taps. The study ...

While Alzheimer’s is a specific disease and the most common cause of dementia, dementia is a broader, "umbrella term that describes a collection of cognitive, functional and behavioral symptoms ...

A cholinergic agonist first developed in the 1990s for Alzheimer’s disease, xanomeline, was approved last year in combination with trospium chloride, a side-effect blocker, for the treatment of ...